Recce Pharmaceuticals Ltd (ASX:RCE)
Australia · Delayed Price · Currency is AUD 0.6200
+0.0200 (3.33%)
Jan 30, 2026, 11:21 AM AEST
Recce Pharmaceuticals Revenue
In the fiscal year ending June 30, 2025, Recce Pharmaceuticals had annual revenue of 7.51M AUD with 49.33% growth. Recce Pharmaceuticals had revenue of 562.52K in the half year ending June 30, 2025, a decrease of -87.11%.
Revenue
7.51M
Revenue Growth
+49.33%
P/S Ratio
23.11
Revenue / Employee
n/a
Employees
n/a
Market Cap
173.51M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 7.51M | 2.48M | 49.33% |
| Jun 30, 2024 | 5.03M | 663.14K | 15.19% |
| Jun 30, 2023 | 4.37M | 1.28M | 41.50% |
| Jun 30, 2022 | 3.08M | 1.45M | 88.41% |
| Jun 30, 2021 | 1.64M | 515.66K | 45.97% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Orthocell | 7.55M |
| Starpharma Holdings | 5.85M |
| Botanix Pharmaceuticals | 5.79M |
| Actinogen Medical | 5.49M |
| Imugene | 4.40M |
| Arovella Therapeutics | 3.44M |
| Proteomics International Laboratories | 3.31M |
| LTR Pharma | 1.51M |
Recce Pharmaceuticals News
- 7 months ago - Security breach laid bare as gangster shot dead inside city hosp; police suspect recce - The Times of India
- 1 year ago - Delhi Police foil terror designs on Independence Day with arrest of 'IS man' - The Times of India